MedPath

Achilles Tendon Repair With Bioinductive Implant

Not Applicable
Completed
Conditions
Tendinopathy
Interventions
Device: Rotation Medical Bioinductive Implant
Registration Number
NCT02811003
Lead Sponsor
Smith & Nephew, Inc.
Brief Summary

To evaluate bioinduction of new tissue and tendon healing after implantation of the Rotation Medical Bioinductive Implant used as adjunct to surgical repair in the treatment of insertional Achilles tendonitis.

Detailed Description

This is a prospective, non-randomized, single-arm study conducted under a common protocol designed to evaluate long-term outcomes following open treatment and implantation of the Rotation Medical Bioinductive Implant to treat insertional Achilles tendinopathy.

Up to 20 subjects will be enrolled and treated with the Rotation Medical Bioinductive Implant.

Enrollment is anticipated to take up to 12 months and all subjects will be followed for two years after surgery. Therefore, the overall study duration is estimated to be 36 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  1. At least 21 years of age

  2. Insertional Achilles tendonitis requiring surgery that has failed conservative management, which consist of:

    A. Shoe modification B. Nonsteroidal anti-inflammatory drugs C. Physical Therapy with/without modalities

  3. Chronic Achilles tendon pain lasting longer than 3 months

  4. MRI or X-ray of the ankle within 60 days prior to the study procedure

  5. Willing to comply with the prescribed post-operative rehabilitation program

  6. Willing to be available for each protocol-required follow-up examination

  7. Able to understand the informed consent process, including regulatory requirements such as HIPAA authorization, and document informed consent prior to completion of any study-related procedures

  8. Ability to read, understand, and complete subject-reported outcomes in English

Exclusion Criteria
  1. Achilles tendon rupture
  2. Previous Achilles tendon surgery on the index ankle
  3. Genetic collagen disease
  4. History of auto-immune or immunodeficiency disorders
  5. History of chronic inflammatory disorders
  6. Oral steroid use in last 2 months or injectable steroid use in last 4 weeks
  7. History of heavy smoking (> 1 pack per day) within last 6 months
  8. Hypersensitivity to bovine-derived materials
  9. Hypersensitivity to Polylactic Acid (PLA) and Polyetheretherketone (PEEK) materials
  10. Metal implants, fillings, shrapnel, and/or screws
  11. Females of child-bearing potential who are pregnant or plan to become pregnant during the course of the study
  12. Currently involved in any injury litigation or worker's compensation claims relating to the index ankle
  13. Enrolled, or plans to enroll, in another clinical trial during this study that would affect the outcomes of this study
  14. History of non-compliance with medical treatment, physical therapy/rehabilitation, or clinical study participation
  15. History of cognitive or mental health status that interferes with study participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TreatmentRotation Medical Bioinductive ImplantTreatment with Rotation Medical Bioinductive Implant
Primary Outcome Measures
NameTimeMethod
MRI Measurements of Tendon Thickening (Combined Tendon and New Tissue)3, 12, and 24 months

Combined measurement of tendon and new tissue thickness in millimeters will be made from sagittal magnetic resonance imaging (MRI) at the insertion (approximately 5-10mm proximal to the bone anchor).

New Tissue Thickness3, 12, and 24 months

Measurement of new tissue thickness in millimeters will be made from sagittal magnetic resonance imaging (MRI) at the level of the bone anchor. These measurements were made distal to the attachment of the Achilles tendon, which do not include the thickness of the repaired tendon; therefore, these thicknesses represent the thickness of the newly induced tissue only.

Tear Ratefollowing surgery to end of treatment at 24 months

Tear rate in the deep portion of the repair at the calcaneus following Achilles surgery will be assessed at each follow-up visit using magnetic resonance imaging (MRI).

Secondary Outcome Measures
NameTimeMethod
Participant Satisfaction12 months

Participant Satisfaction will determined based on the response to the statement "I am satisfied with the results of my surgery." The response will be assessed with a 5-point Likert scale, which has 1 - very dissatisfied, 2 - dissatisfied, 3 - neither satisfied nor dissatisfied, 4 - satisfied, 5 - very satisfied

Device Implant TimeIntraoperatively, up to 9 minutes

Time in minutes from introduction of the bioinductive implant into the surgical field to completion of the last staple

CAM Boot Time1 week following surgery to 12 months

Cumulative number of days spent in a controlled ankle motion walking boot (CAM boot).

Rehabilitation Visits4 weeks following surgery to end of treatment at 24 months

Rehabilitation measured by the cumulative number of completed rehabilitation or physical therapy (PT) visits to treat index Achilles.

Time to Recoveryfollowing surgery to end of treatment at 24 months

Recovery will be measured by days to return to normal daily activity (i.e. full, unrestricted activity).

Number of Participants With Procedure Technical SuccessIntraoperatively, up to 9 minutes

The number of participants where the device was successfully delivered and affixed to target tendon location (i.e., study device was successfully implanted).

Trial Locations

Locations (2)

MedStar Union Memorial Hospital

🇺🇸

Baltimore, Maryland, United States

Allegheny Health Network

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath